ANALYTICS
Licensing settled, ApexCharts is back to changing what a chart can take as input.
Alternatives · analytics tools
DoseFinding alternatives
The best DoseFinding alternatives in analytics tools, ranked by Sparkpulse's velocity_score.
Updated Aug 19, 2026
Looking for the best alternatives to DoseFinding? Sparkpulse tracks and ranks 12 alternatives in analytics tools by shipping velocity — how frequently each ships meaningful updates, verified from official changelogs. For reference, DoseFinding shipped 0 meaningful updates in the last 30 days and carries a velocity score of 0.0 out of 10 in 2026. The alternatives below are ranked the same way, so you're comparing real release momentum, not marketing claims.
About DoseFinding
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
Velocity 0.0 · Last update 4d ago
Top 12 alternatives to DoseFinding
Ranked by recent ship velocity. Tap any card for the full editorial breakdown, or pivot to a head-to-head.
ANALYTICS
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
ANALYTICS
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
ANALYTICS
Rho's release machinery finally produced a stable build — and it shipped no new product.
ANALYTICS
OpenCTI spends a release unblocking queues and hardening upserts
ANALYTICS
After its largest release, OpenObserve is patching the seams.
ANALYTICS
AgencyAnalytics is turning its assistant into scheduled agency staff work, not a chat box.
ANALYTICS
silx settles into maintenance a release after its PySide6 migration
ANALYTICS
Mimir's feed is a weekly Helm bot, with the 3.2 candidate the only real release in months
ANALYTICS
Dovetail spent July opening doors to other tools; August is spent making its own rooms easier to enter.
ANALYTICS
TimescaleDB is paying down correctness debt in its columnstore query paths.
ANALYTICS
Holistics is adding governance to the AI layer it spent the summer building.
DoseFinding vs alternatives — shipping velocity at a glance
Velocity score (0–10) and meaningful releases shipped in the last 30 days, from official changelogs. Higher = shipping faster.
| Product | Velocity | Sparks · 30d | Focus areas | Latest release |
|---|---|---|---|---|
| DoseFinding (baseline) | 0.0 | 0 | dose-responsemcp-modclinical-trials | Model averaging arrives for dose-response fitting |
| ApexCharts | 10.0 | 3 | chartingraw-data-inputchart-morphing | Histogram bins raw samples; charts morph between types |
| Usermaven | 8.8 | 3 | product-analyticsreverse-etlmcp | 🔌 Salesforce, Reverse ETL, and connectors: your stack, connected |
| Plotly | 6.3 | 1 | ai-app-buildingplotly-cloudmetered-billing | Custom Domains in Plotly Cloud |
| Rho | 6.3 | 1 | r-ideai-agentsmodel-routing | Agent conversations and provider-routed models land in Rho |
| OpenCTI | 6.3 | 0 | threat-intelligencestixdata-model | — |
| OpenObserve | 6.3 | 1 | observabilitysynthetic-monitoringmcp | v0.92.0 adds synthetic monitoring, workflows, and AI observability |
| AgencyAnalytics | 6.3 | 1 | agency-reportingai-assistantscheduling | Skills in AgencyAI |
| silx | 5.0 | 0 | scientific-computingdata-visualizationsynchrotron | 3.0.0: PySide6 becomes the default Qt binding, Python 3.10 required |
| Grafana Mimir | 5.0 | 0 | metricsprometheus-compatiblehelm | — |
| Dovetail | 5.0 | 0 | digital twinschatagents | — |
| TimescaleDB | 5.0 | 0 | time-seriespostgresqlcolumnstore | — |
| Holistics | 5.0 | 0 | business-intelligenceai-governanceanalytics-as-code | — |
The 12 best DoseFinding alternatives, in depth
1. ApexCharts · velocity 10.0
Licensing settled, ApexCharts is back to changing what a chart can take as input.
Over the last 30 days ApexCharts shipped 3 meaningful updates vs DoseFinding's 0, most recently “Histogram bins raw samples; charts morph between types”. Its velocity score of 10.0/10 blends that with longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, ApexCharts focuses on charting, raw data input and chart morphing.
Over the last 30 days ApexCharts has been shipping faster than DoseFinding — a point in its favour if release momentum matters to you.
Full ApexCharts trajectory → · Compare DoseFinding vs ApexCharts →
2. Usermaven · velocity 8.8
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
Over the last 30 days Usermaven shipped 3 meaningful updates vs DoseFinding's 0, most recently “🔌 Salesforce, Reverse ETL, and connectors: your stack, connected”. Its velocity score of 8.8/10 blends that with longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, Usermaven focuses on product analytics, reverse etl and mcp.
Over the last 30 days Usermaven has been shipping faster than DoseFinding — a point in its favour if release momentum matters to you.
Full Usermaven trajectory → · Compare DoseFinding vs Usermaven →
3. Plotly · velocity 6.3
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
Over the last 30 days Plotly shipped 1 meaningful update vs DoseFinding's 0, most recently “Custom Domains in Plotly Cloud”. Its velocity score of 6.3/10 blends that with longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, Plotly focuses on ai app building, plotly cloud and metered billing.
Over the last 30 days Plotly has been shipping faster than DoseFinding — a point in its favour if release momentum matters to you.
4. Rho · velocity 6.3
Rho's release machinery finally produced a stable build — and it shipped no new product.
Over the last 30 days Rho shipped 1 meaningful update vs DoseFinding's 0, most recently “Agent conversations and provider-routed models land in Rho”. Its velocity score of 6.3/10 blends that with longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, Rho focuses on r ide, ai agents and model routing.
Over the last 30 days Rho has been shipping faster than DoseFinding — a point in its favour if release momentum matters to you.
5. OpenCTI · velocity 6.3
OpenCTI spends a release unblocking queues and hardening upserts.
Its velocity score of 6.3/10 reflects longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, OpenCTI focuses on threat intelligence, stix and data model.
OpenCTI and DoseFinding have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full OpenCTI trajectory → · Compare DoseFinding vs OpenCTI →
6. OpenObserve · velocity 6.3
After its largest release, OpenObserve is patching the seams.
Over the last 30 days OpenObserve shipped 1 meaningful update vs DoseFinding's 0, most recently “v0.92.0 adds synthetic monitoring, workflows, and AI observability”. Its velocity score of 6.3/10 blends that with longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, OpenObserve focuses on observability, synthetic monitoring and mcp.
Over the last 30 days OpenObserve has been shipping faster than DoseFinding — a point in its favour if release momentum matters to you.
Full OpenObserve trajectory → · Compare DoseFinding vs OpenObserve →
7. AgencyAnalytics · velocity 6.3
AgencyAnalytics is turning its assistant into scheduled agency staff work, not a chat box.
Over the last 30 days AgencyAnalytics shipped 1 meaningful update vs DoseFinding's 0, most recently “Skills in AgencyAI”. Its velocity score of 6.3/10 blends that with longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, AgencyAnalytics focuses on agency reporting, ai assistant and scheduling.
Over the last 30 days AgencyAnalytics has been shipping faster than DoseFinding — a point in its favour if release momentum matters to you.
Full AgencyAnalytics trajectory → · Compare DoseFinding vs AgencyAnalytics →
8. silx · velocity 5.0
Silx settles into maintenance a release after its PySide6 migration.
Its velocity score of 5.0/10 reflects longer-term release cadence; its most recent meaningful update was “3.0.0: PySide6 becomes the default Qt binding, Python 3.10 required”.
Where DoseFinding leans on dose response, mcp mod and clinical trials, silx focuses on scientific computing, data visualization and synchrotron.
silx and DoseFinding have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
9. Grafana Mimir · velocity 5.0
Mimir's feed is a weekly Helm bot, with the 3.2 candidate the only real release in months.
Its velocity score of 5.0/10 reflects longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, Grafana Mimir focuses on metrics, prometheus compatible and helm.
Grafana Mimir and DoseFinding have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full Grafana Mimir trajectory → · Compare DoseFinding vs Grafana Mimir →
10. Dovetail · velocity 5.0
Dovetail spent July opening doors to other tools; August is spent making its own rooms easier to enter.
Its velocity score of 5.0/10 reflects longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, Dovetail focuses on digital twins, chat and agents.
Dovetail and DoseFinding have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full Dovetail trajectory → · Compare DoseFinding vs Dovetail →
11. TimescaleDB · velocity 5.0
TimescaleDB is paying down correctness debt in its columnstore query paths.
Its velocity score of 5.0/10 reflects longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, TimescaleDB focuses on time series, postgresql and columnstore.
TimescaleDB and DoseFinding have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full TimescaleDB trajectory → · Compare DoseFinding vs TimescaleDB →
12. Holistics · velocity 5.0
Holistics is adding governance to the AI layer it spent the summer building.
Its velocity score of 5.0/10 reflects longer-term release cadence.
Where DoseFinding leans on dose response, mcp mod and clinical trials, Holistics focuses on business intelligence, ai governance and analytics as code.
Holistics and DoseFinding have shipped at a similar pace over the last 30 days, so the decision comes down to fit and feature depth.
Full Holistics trajectory → · Compare DoseFinding vs Holistics →
Frequently asked questions
What are the best alternatives to DoseFinding?
The top DoseFinding alternatives we currently track in analytics tools are ApexCharts, Usermaven, Plotly, Rho, OpenCTI, ranked by recent ship velocity.
How is this list of DoseFinding alternatives ranked?
Alternatives are ranked by Sparkpulse's velocity_score — release cadence + 30-day spark count + sector-relative ship rate.
Can I compare DoseFinding directly with one of these alternatives?
Yes — every card has a "Compare with DoseFinding" link to a side-by-side /compare page.